Applied Genetic Technologies (NASDAQ: AGTC)
Some price data may be temporarily unavailable.
Applied Genetic Technologies Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Applied Genetic Technologies Company Info
Applied Genetics Technologies Corporation (AGTC) is developing therapies designed to transform the lives of patients with severe diseases, offering hope to patients with unmet medical needs. With a highly specialized team of physicians and researchers, They use cutting-edge techniques to develop treatments for patients that have diseases caused by broken genes. They use gene therapy, which replaces those broken genes with normal functional genes, allowing a patient’s own body to produce proteins to treat their illness. A single injection provides long-lasting treatment, leading to a better quality of life for patients worldwide.
News & Analysis
Why Applied Genetic Technologies Corp. Is Tanking Today
Traders rush for the exits in response to the company's fiscal-fourth-quarter earnings report and to an announced delay in two of its ongoing clinical studies.
Biogen Sees Promise in Gene Therapy
Multiple programs are in development.
Why Applied Genetic Technologies Corporation Stock Jumped Today
Shares of Applied Genetic Technologies Corporation bolted higher today. Here's why.
3 Stocks Near 52-Week Highs Worth Selling
Are these three stocks sells or belles? You be the judge!
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.